20/20 Biolabs Inc (AIDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 03-2025 | |
| Sales | 353 | 0 | 554 |
| Cost of Goods | 291 | N/A | 388 |
| Gross Profit | 63 | N/A | 166 |
| Operating Expenses | 1,797 | 0 | 1,326 |
| Operating Income | -1,443 | N/A | -772 |
| Interest Expense | 267 | 0 | 1 |
| Other Income | -464 | 0 | 8 |
| Pre-tax Income | -2,175 | 0 | -765 |
| Net Income Continuous | -2,175 | N/A | -765 |
| Net Income | $-2,175 | $N/A | $-765 |
| EPS Basic Total Ops | -0.28 | N/A | -0.16 |
| EPS Basic Continuous Ops | -0.28 | N/A | -0.16 |
| EPS Diluted Total Ops | -0.28 | N/A | -0.16 |
| EPS Diluted Continuous Ops | -0.28 | N/A | -0.16 |
| EBITDA(a) | $-1,188 | $N/A | $-751 |